In this study, we extended our bead-coupled LDR assay from synthetic oligonucleotides to genomic DNA extracted from colorectal cancer cell lines, enabling reliable identification of clinically relevant KRAS codon 12 mutations. The gene discussed is KRAS; the disease is colorectal cancer.